TI - Real-life Comparison of FOLFOX-6 and Modified DCF Regimens for the First-Line Treatment of HER-2 Negative Metastatic Gastric Cancer
PT - Journal Article
DP - 2026
TA - EJMI
PG - 337-344
VI - 10
IP - 3
AID - 269337 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.269337
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2026 10(3): 337